Edgar Rangel‐López

1.3k total citations
55 papers, 996 citations indexed

About

Edgar Rangel‐López is a scholar working on Molecular Biology, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Edgar Rangel‐López has authored 55 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pharmacology and 10 papers in Biological Psychiatry. Recurrent topics in Edgar Rangel‐López's work include Cannabis and Cannabinoid Research (13 papers), Tryptophan and brain disorders (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Edgar Rangel‐López is often cited by papers focused on Cannabis and Cannabinoid Research (13 papers), Tryptophan and brain disorders (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Edgar Rangel‐López collaborates with scholars based in Mexico, United States and Spain. Edgar Rangel‐López's co-authors include Abel Santamarı́a, Benjamín Pineda, Ana Laura Colín-González, Julio Sotelo, Norma Hernández‐Pedro, Isaac Túnez, Michael Aschner, Verónica Pérez de la Cruz, Anahí Chavarría and Gustavo Cabrera and has published in prestigious journals such as Neuroscience, Molecules and Antioxidants and Redox Signaling.

In The Last Decade

Edgar Rangel‐López

53 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar Rangel‐López Mexico 19 343 191 120 106 83 55 996
Hye Lim Lee South Korea 21 547 1.6× 185 1.0× 77 0.6× 124 1.2× 113 1.4× 101 1.2k
Л. І. Остапченко Ukraine 21 459 1.3× 142 0.7× 121 1.0× 54 0.5× 113 1.4× 179 1.3k
Marı́a José De Rosa Argentina 15 828 2.4× 89 0.5× 151 1.3× 73 0.7× 91 1.1× 25 1.5k
Liyun Shi China 22 519 1.5× 81 0.4× 66 0.6× 82 0.8× 60 0.7× 60 1.2k
Ning Yao China 18 486 1.4× 101 0.5× 168 1.4× 37 0.3× 70 0.8× 54 1.2k
Mehdi Rezaee Iran 15 494 1.4× 149 0.8× 52 0.4× 79 0.7× 81 1.0× 32 1.0k
Krishna Banaudha United States 17 472 1.4× 77 0.4× 162 1.4× 101 1.0× 61 0.7× 24 1.5k
Amos A. Fatokun United Kingdom 20 743 2.2× 87 0.5× 101 0.8× 119 1.1× 78 0.9× 60 1.7k
Belém Sampaio‐Marques Portugal 22 846 2.5× 92 0.5× 88 0.7× 151 1.4× 59 0.7× 55 1.5k

Countries citing papers authored by Edgar Rangel‐López

Since Specialization
Citations

This map shows the geographic impact of Edgar Rangel‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Rangel‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Rangel‐López more than expected).

Fields of papers citing papers by Edgar Rangel‐López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Rangel‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Rangel‐López. The network helps show where Edgar Rangel‐López may publish in the future.

Co-authorship network of co-authors of Edgar Rangel‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Rangel‐López. A scholar is included among the top collaborators of Edgar Rangel‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Rangel‐López. Edgar Rangel‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega, Daniela Ramírez, Tonali Blanco Ayala, Dinora F. González‐Esquivel, et al.. (2024). Modulation of Brain Kynurenic Acid by N-Acetylcysteine Prevents Cognitive Impairment and Muscular Weakness Induced by Cisplatin in Female Rats. Cells. 13(23). 1989–1989. 5 indexed citations
2.
Rangel‐López, Edgar, Isaac Túnez, Alexey A. Tinkov, et al.. (2024). Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence. Neurotoxicity Research. 42(2). 3 indexed citations
3.
Sánchez‐Chapul, Laura, Abel Santamarı́a, Michael Aschner, et al.. (2023). Thallium-induced DNA damage, genetic, and epigenetic alterations. Frontiers in Genetics. 14. 1168713–1168713. 24 indexed citations
4.
Rangel‐López, Edgar, et al.. (2023). Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms. Pharmaceuticals. 16(10). 1421–1421. 2 indexed citations
5.
Rangel‐López, Edgar, Sonia Galván‐Arzate, Cecilia Zazueta, et al.. (2022). Thallium Induces Antiproliferative and Cytotoxic Activity in Glioblastoma C6 and U373 Cell Cultures via Apoptosis and Changes in Cell Cycle. Neurotoxicity Research. 40(3). 814–824. 7 indexed citations
9.
Elmazoğlu, Zübeyir, Abel Santamarı́a, Edgar Rangel‐López, et al.. (2021). Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis. Neurochemical Research. 46(12). 3325–3341. 10 indexed citations
10.
Rangel‐López, Edgar, et al.. (2021). The Endocannabinoid System in Caenorhabditis elegans. Reviews of physiology, biochemistry and pharmacology. 184. 1–31. 9 indexed citations
11.
Rangel‐López, Edgar, Erika Ruíz‐García, Abelardo Meneses‐García, et al.. (2020). Oleamide Induces Cell Death in Glioblastoma RG2 Cells by a Cannabinoid Receptor–Independent Mechanism. Neurotoxicity Research. 38(4). 941–956. 9 indexed citations
13.
Rangel‐López, Edgar, Alejandro Silva‐Palacios, Sonia Galván‐Arzate, et al.. (2019). Comparing the Neuroprotective Effects of Caffeic Acid in Rat Cortical Slices and Caenorhabditis elegans: Involvement of Nrf2 and SKN-1 Signaling Pathways. Neurotoxicity Research. 37(2). 326–337. 25 indexed citations
14.
Serratos, Iris N., Nina Pastor, César Millán‐Pacheco, et al.. (2016). Early expression of the receptor for advanced glycation end products in a toxic model produced by 6-hydroxydopamine in the rat striatum. Chemico-Biological Interactions. 249. 10–18. 7 indexed citations
15.
Hernández‐Pedro, Norma, Vinicio Granados‐Soto, Graciela Ordóñez, et al.. (2014). Vitamin A increases nerve growth factor and retinoic acid receptor beta and improves diabetic neuropathy in rats. Translational research. 164(3). 196–201. 18 indexed citations
16.
Rangel‐López, Edgar, Ana Laura Colín-González, Enrique Pinzón, et al.. (2014). Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain. Neuroscience. 285. 97–106. 45 indexed citations
17.
Hernández‐Pedro, Norma, Edgar Rangel‐López, Verónica Pérez de la Cruz, et al.. (2013). Application of Nanoparticles on Diagnosis and Therapy in Gliomas. BioMed Research International. 2013. 1–20. 65 indexed citations
18.
Manoutcharian, Karen, Norma Hernández‐Pedro, Edgar Rangel‐López, et al.. (2013). Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma. Journal of Cancer Research and Clinical Oncology. 140(2). 291–301. 15 indexed citations
19.
Colín-González, Ana Laura, Marisol Orozco‐Ibarra, María Elena Chánez‐Cárdenas, et al.. (2012). Heme oxygenase-1 (HO-1) upregulation delays morphological and oxidative damage induced in an excitotoxic/pro-oxidant model in the rat striatum. Neuroscience. 231. 91–101. 32 indexed citations
20.
Segura-Pacheco, Blanca, et al.. (2007). HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo. PubMed. 5(1). 10–10. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026